Literature DB >> 18043538

PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.

H Herzog1, L Tellmann, B Scholten, H H Coenen, S M Qaim.   

Abstract

AIM: Positron emission tomography (PET) imaging of non-standard positron emitters is influenced by gamma-coincidences, i.e. false coincidences produced by the coincident detection of an annihilation photon and a gamma-ray simultaneously emitted with the positron. The extent to which the PET study is disturbed by this effect is dependent on the kind of the positron emitter used, the kind and position of the object, the acquisition mode, i.e. the optional use of septa, and the reconstruction program. In order to demonstrate and study imaging problems with non-standard positron emitters, a phantom was scanned containing non-radioactive rods with different absorption materials and filled with either (124)I or (86)Y in the bidimensional (2D) as well as tridimensional (3D) acquisition mode.
METHODS: For reconstruction, the PET manufacturer's standard software without any modification was used. To reduce errors caused by the gamma-coincidences, a simple linear background subtraction, estimated from the counts at the scanner's external radius, was applied.
RESULTS: Without background subtraction, apparent positive and negative ''radioactivity concentrations'' were found in regions of interest positioned over the non-radioactive rods with values higher for (86)Y compared to (124)I and also higher for 3D compared to 2D. A complete subtraction of the background led to erroneous
RESULTS: The errors in the phantom's non-radioactive rods and the difference between measured and true radioactivity became minimum, when about 75% of the background was subtracted. This refers to both the 2D and 3D mode.
CONCLUSION: Quantitation problems with the non-standard positron emitters (124)I and (86)Y could be minimized in the phantom study examined here by using a simple background subtraction together with the manufacturer's standard correction and reconstruction procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043538

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  15 in total

1.  PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.

Authors:  Tapan K Nayak; Kayhan Garmestani; Kwamena E Baidoo; Diane E Milenic; Martin W Brechbiel
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

2.  Is PET always an advantage versus planar and SPECT imaging?

Authors:  Giuliano Mariani; Laura Bruselli; Adriano Duatti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 3.  Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Authors:  Stephan Walrand; Glenn D Flux; Mark W Konijnenberg; Roelf Valkema; Eric P Krenning; Renaud Lhommel; Stanislas Pauwels; Francois Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-11       Impact factor: 9.236

4.  PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

Authors:  Tapan K Nayak; Celeste A S Regino; Karen J Wong; Diane E Milenic; Kayhan Garmestani; Kwamena E Baidoo; Lawrence P Szajek; Martin W Brechbiel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-13       Impact factor: 9.236

5.  Is bone marrow uptake of ⁸⁶Y-DOTATOC routinely observed?

Authors:  Stephan Walrand; Stanislas Pauwels; François Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

Review 6.  Mapping biological behaviors by application of longer-lived positron emitting radionuclides.

Authors:  Yang Zhou; Kwamena E Baidoo; Martin W Brechbiel
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 7.  Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Authors:  Egesta Lopci; Arturo Chiti; Maria Rita Castellani; Giovanna Pepe; Lidija Antunovic; Stefano Fanti; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

Review 8.  Quantitative imaging of 124I and 86Y with PET.

Authors:  Mark Lubberink; Hans Herzog
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

Review 9.  Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.

Authors:  Eszter Boros; Jason P Holland
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

10.  86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics.

Authors:  Carolina A Ferreira; Emily B Ehlerding; Zachary T Rosenkrans; Dawei Jiang; Tuanwei Sun; Eduardo Aluicio-Sarduy; Jonathan W Engle; Dalong Ni; Weibo Cai
Journal:  Mol Pharm       Date:  2020-03-31       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.